Tested Applications
| Positive WB detected in | human liver tissue |
| Positive IHC detected in | human liver tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
17035-1-AP targets GALT in WB, IHC, IF, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag10524 Product name: Recombinant human GALT protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-379 aa of BC015045 Sequence: MSRSGTDPQQRQQASEADAAAATFRANDHQHIRYNPLQDEWVLVSAHRMKRPWQGQVEPQLLKTVPRHDPLNPLCPGAIRANGEVNPQYDSTFLFDNDFPALQPDAPSPGPSDHPLFQAKSARGVCKVMCFHPWSDVTLPLMSVPEIRAVVDAWASVTEELGAQYPWVQIFENKGAMMGCSNPHPHCQVWASSFLPDIAQREERSQQAYKSQHGEPLLMEYSRQELLRKERLVLTSEHWLVLVPFWATWPYQTLLLPRRHVRRLPELTPAERDDLASIMKKLLTKYDNLFETSFPYSMGWHGAPTGSEAGANWDHWQLHAHYYPPLLRSATVRKFMVGYEMLAQAQRDLTPEQAAERLRALPEVHYHLGQKDRETATIA Predict reactive species |
| Full Name | galactose-1-phosphate uridylyltransferase |
| Calculated Molecular Weight | 379 aa, 43 kDa |
| Observed Molecular Weight | 45-48 kDa |
| GenBank Accession Number | BC015045 |
| Gene Symbol | GALT |
| Gene ID (NCBI) | 2592 |
| RRID | AB_2109296 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P07902 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
GALT (galactose-1-phosphate uridylyltransferase) catalyses the second step in the Leloir pathway for the conversion of galactose-l-phosphate (Gal-I-P) into uridine diphosphogalactose (UDP-gal). Defects in GALT cause galactosemia.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for GALT antibody 17035-1-AP | Download protocol |
| WB protocol for GALT antibody 17035-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The GALT Polyclonal antibody (catalog no. 17035-1-AP) has 3 total citations. These appear in Frontiers in Molecular Biosciences (2025), Journal of Inherited Metabolic Disease (2019), and PLoS One (2014). The associated research fields include Golgi membrane protein dimerization and UDP-Gal biosynthesis, galactose metabolism and GALT activity, and chondrocyte gene expression related to anti-osteoarthritis activity. Applications cited were Western blot and immunofluorescence in human samples.
| Species | Application | Title |
|---|---|---|
Front Mol Biosci Cytosolic UDP-Gal biosynthetic machinery is required for dimerization of SLC35A2 in the Golgi membrane and its interaction with B4GalT1 | ||
J Inherit Metab Dis Galactose 1-phosphate accumulates to high levels in galactose-treated cells due to low GALT activity and absence of product inhibition of GALK. | ||
PLoS One Angelica Sinensis Polysaccharides Stimulated UDP-Sugar Synthase Genes through Promoting Gene Expression of IGF-1 and IGF1R in Chondrocytes: Promoting Anti-Osteoarthritic Activity. |







